Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

AbbVie Inc. (ABBV)

Compare
208.93
+3.64
+(1.77%)
As of 2:26:32 PM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 15.1B
Earnings -22M

Q1'24

Q2'24

Q3'24

Q4'24

0
5B
10B
15B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

173.00 Low
211.73 Average
208.93 Current
250.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 15152425
Avg. Estimate 2.513.0912.2813.88
Low Estimate 2.482.9512.0112.72
High Estimate 2.613.3212.6714.96
Year Ago EPS 2.312.6510.1212.28

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 14132323
Avg. Estimate 12.91B14.72B59.36B64.21B
Low Estimate 12.77B14.35B57.2B61.02B
High Estimate 13.35B15.03B60.57B66.64B
Year Ago Sales 12.31B14.46B56.33B59.36B
Sales Growth (year/est) 4.91%1.75%5.38%8.16%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 2.262.662.922.12
EPS Actual 2.312.6532.16
Difference 0.05-0.010.080.04
Surprise % 2.37%-0.39%2.82%1.92%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 2.513.0912.2813.88
7 Days Ago 2.523.0912.2813.9
30 Days Ago 2.523.0812.2613.81
60 Days Ago 2.633.1812.1913.72
90 Days Ago 2.623.1812.1813.65

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1--33
Up Last 30 Days 1176
Down Last 7 Days ----1--
Down Last 30 Days 1--33

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ABBV 8.66%16.59%21.32%13.09%
S&P 500 16.20%6.69%10.00%14.33%

Upgrades & Downgrades

Maintains Wells Fargo: Overweight to Overweight 3/5/2025
Maintains B of A Securities: Neutral to Neutral 3/4/2025
Maintains Citigroup: Buy to Buy 2/3/2025
Maintains Truist Securities: Buy to Buy 2/3/2025
Maintains UBS: Neutral to Neutral 2/3/2025
Maintains Wells Fargo: Overweight to Overweight 2/3/2025

Related Tickers